Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77701-77750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06011460
Observation of Clozapine Treatment Safety in Bipolar Disorder.
N/AEnrolling by invitation
30 participants
Started: Feb 23, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05608252
VS-6766+Abema+Fulv in Met HR+/HER- BC
PHASE1/PHASE2Recruiting
63 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2028
3 conditions3 sponsors3 locations
NCT05648240
Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients with Versus Without Intestinal Polyps
N/ARecruiting
120 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT05523869
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
PHASE2Recruiting
50 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT05182749
Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis
PHASE1/PHASE2Active, not recruiting
52 participants
Started: Feb 23, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05676450
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NARecruiting
517 participants
Started: Feb 23, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT06238882
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
NARecruiting
74 participants
Started: Feb 23, 2023 · Completed: Feb 15, 2026
3 conditions1 sponsor1 location
NCT05551741
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
PHASE1Active, not recruiting
40 participants
Started: Feb 23, 2023 · Completed: Nov 1, 2025
1 condition3 sponsors10 locations
NCT05091710
Haiti Community Health Workers (CHW) Adaptation
NAActive, not recruiting
28 participants
Started: Feb 23, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05718856
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
PHASE4Recruiting
166 participants
Started: Feb 23, 2023 · Completed: Nov 14, 2025
1 condition7 sponsors1 location
NCT05656469
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
NARecruiting
2,500 participants
Started: Feb 23, 2023 · Completed: Sep 30, 2026
3 conditions9 sponsors9 locations
NCT05469360
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
PHASE1Recruiting
36 participants
Started: Feb 23, 2023 · Completed: Jan 2, 2028
2 conditions1 sponsor10 locations
NCT05101551
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
PHASE1Recruiting
34 participants
Started: Feb 23, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors9 locations
NCT05606146
IUB SEAD RED (Revolutionary Endometrial Ablation Device Study)
NARecruiting
10 participants
Started: Feb 23, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT06312969
Technological Gaming in Cancer Survivors (WINNERS)
NARecruiting
56 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2025
1 condition3 sponsors1 location
NCT06018558
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Feb 23, 2023 · Completed: May 29, 2026
1 condition1 sponsor12 locations
NCT05027945
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
PHASE2Recruiting
54 participants
Started: Feb 23, 2023 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location
NCT06419049
Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design
NARecruiting
12 participants
Started: Feb 23, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05699811
IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
40 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05394337
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
PHASE1/PHASE2Recruiting
10 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04663399
IMMunological ResPonse Assessment AfteR Acute ISchemic Stroke Treated with Endovascular Therapy (IMPRESS)
N/ARecruiting
400 participants
Started: Feb 23, 2023 · Completed: May 23, 2028
2 conditions1 sponsor1 location
NCT05704647
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
PHASE2Recruiting
30 participants
Started: Feb 23, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05642507
Phase Ib/IIa Trial With AC01 in Patients With HFrEF
PHASE1/PHASE2Active, not recruiting
62 participants
Started: Feb 23, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor13 locations
NCT05807763
Fundoplication in Laparoscopic PEH Repair Based on FLIP
NAEnrolling by invitation
260 participants
Started: Feb 22, 2023 · Completed: Feb 22, 2029
1 condition1 sponsor2 locations
NCT05511389
Anteroposterior Versus Anterolateral Electrode Position for Electrical Cardioversion of Atrial Fibrillation
NARecruiting
1,500 participants
Started: Feb 22, 2023 · Completed: Jul 31, 2027
2 conditions1 sponsor2 locations
NCT05191485
Shared Decision Making in Patients With Lung Cancer
N/ARecruiting
190 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2026
2 conditions5 sponsors1 location
NCT05717179
Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach
NARecruiting
158 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2029
3 conditions1 sponsor1 location
NCT06394349
Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo
NARecruiting
20 participants
Started: Feb 22, 2023 · Completed: Oct 14, 2024
1 condition1 sponsor1 location
NCT05683041
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
NARecruiting
30 participants
Started: Feb 22, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT05754944
Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery
N/AActive, not recruiting
114 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06113835
Viable Myocardium Detected by Hybrid PET/MR and SPECT for the Prediction of the Efficacy of PCI in Patients With CTO.
N/ARecruiting
80 participants
Started: Feb 22, 2023 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT06261970
Increase First-time Mothers' Use of Postpartum Family Planning in Tanzania: The Connect Project
NAActive, not recruiting
1,134 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors2 locations
NCT05777889
Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients
N/ARecruiting
10 participants
Started: Feb 22, 2023 · Completed: Feb 22, 2026
1 condition1 sponsor1 location
NCT05594992
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
PHASE3Enrolling by invitation
80 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2028
1 condition1 sponsor9 locations
NCT06181942
A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries
N/ARecruiting
15 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05728762
Light Emitting Diodes With a Continuous Spectrum of 430-780nm for Myopia Prevention
NAActive, not recruiting
1,920 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05382650
Survey of Human Rabies Immune Globulin Safety in Children
N/ARecruiting
50 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors2 locations
NCT05557838
Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma
PHASE3Recruiting
210 participants
Started: Feb 22, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor32 locations
NCT05599139
Iodine Uptake After a Low Iodine Diet
NARecruiting
25 participants
Started: Feb 22, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05800587
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
PHASE2Recruiting
280 participants
Started: Feb 22, 2023 · Completed: Aug 1, 2029
3 conditions1 sponsor1 location
NCT05596773
Community-Based Chronic Disease Care in Rural Lesotho
N/ARecruiting
16,000 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors2 locations
NCT05620173
Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT)
NAActive, not recruiting
74 participants
Started: Feb 22, 2023 · Completed: Dec 1, 2024
3 conditions6 sponsors2 locations
NCT04992104
Microbiome and Malnutrition in Pregnancy
N/ARecruiting
800 participants
Started: Feb 22, 2023 · Completed: Mar 31, 2027
12 conditions9 sponsors2 locations
NCT06160635
D-SOLVE Cohorts (Cohort a and B)
N/ARecruiting
750 participants
Started: Feb 22, 2023 · Completed: Sep 30, 2026
3 conditions6 sponsors4 locations
NCT05740605
Implementation of a HABIT-ILE Intervention at Home for Children With Bilateral Cerebral Palsy
NARecruiting
48 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05704205
The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)
NAActive, not recruiting
316 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors16 locations
NCT05731726
Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer
PHASE2Recruiting
50 participants
Started: Feb 22, 2023 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT05832112
Outside the Cage (OTC) Robotic Lobectomy
NAActive, not recruiting
100 participants
Started: Feb 22, 2023 · Completed: Dec 9, 2024
1 condition1 sponsor1 location
NCT05505942
Physical Activity for PLWH and Unhealthy Drinking
NARecruiting
340 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT05779839
A Study of Caregiver Connections Via Technology in Dementia
NAActive, not recruiting
355 participants
Started: Feb 22, 2023 · Completed: Apr 15, 2026
6 conditions3 sponsors1 location